MX9304601A - ANTIMICROBIAL, ANALGESICAL, ANTI-INFLAMMATORY COMPOSITION, WHICH FAVORS LACICATRIZATION OF WOUNDS, BURNS AND DERMAL ULCERS. - Google Patents

ANTIMICROBIAL, ANALGESICAL, ANTI-INFLAMMATORY COMPOSITION, WHICH FAVORS LACICATRIZATION OF WOUNDS, BURNS AND DERMAL ULCERS.

Info

Publication number
MX9304601A
MX9304601A MX9304601A MX9304601A MX9304601A MX 9304601 A MX9304601 A MX 9304601A MX 9304601 A MX9304601 A MX 9304601A MX 9304601 A MX9304601 A MX 9304601A MX 9304601 A MX9304601 A MX 9304601A
Authority
MX
Mexico
Prior art keywords
lesion
lacicatrization
analgesical
favors
wounds
Prior art date
Application number
MX9304601A
Other languages
Spanish (es)
Inventor
Jose Kirsch Sanchez
Original Assignee
Jose Kirsch Sanchez
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jose Kirsch Sanchez filed Critical Jose Kirsch Sanchez
Priority to MX9304601A priority Critical patent/MX9304601A/en
Publication of MX9304601A publication Critical patent/MX9304601A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Esta composición es una mezcla de alcalinizantes de efecto antipersistente(Gel de Hidróxido de Aluminio y Magnesio) y solución bicarbonatada desodio, con un anestésico local (Clorhidrato de Lidocína y/o Bupivacaína) yantimicrobianos específicos solos o combinados: 1.- Trimetropim conSulfametoxazol, 2.- Rifampicina, 3.- Cloranfenicol 4.- Penicilina SódicaCristalina, 5.- Iodapovidona, 6.- Eritromicina, 7.- Clindamicina, 8.-Aminoclucósidos a).- Amikacina, b).- Gentamicina, c).- Neomicina, d).-Kanamicina, etc., 9.- Nistatina, 10.- Tetraciclina Oxitetraciclina. Seemplea administrandose en promedio de 2 a 3 veces al día localmente previoaseo de la lesión con agua estéril. Los resultados apreciados son:Curación o mejoría de la lesión a corto plazo, permitiendo manejar el áreaafectada con otro tratamiento complementario (Injertos, Colgajos ó CirugíaVascular).This composition is a mixture of alkalinizers with an antipersistent effect (Aluminum Magnesium Hydroxide Gel) and sodium bicarbonate solution, with a local anesthetic (Lidocine Hydrochloride and / or Bupivacaine) and specific antimicrobials alone or in combination: 1.- Trimethropim with Sulfamethoxazole, 2 .- Rifampicin, 3.- Chloramphenicol 4.- Penicillin SodiumCrystalline, 5.- Iodapovidone, 6.- Erythromycin, 7.- Clindamycin, 8.-Aminoclucosides a) .- Amikacin, b) .- Gentamicin, c) .- Neomycin , d) .- Kanamycin, etc., 9.- Nystatin, 10.- Tetracycline Oxytetracycline. It is used by administering an average of 2 to 3 times a day locally after cleaning the lesion with sterile water. The results appreciated are: Healing or improvement of the lesion in the short term, allowing the affected area to be managed with another complementary treatment (Grafts, Flaps or Vascular Surgery).

MX9304601A 1993-07-30 1993-07-30 ANTIMICROBIAL, ANALGESICAL, ANTI-INFLAMMATORY COMPOSITION, WHICH FAVORS LACICATRIZATION OF WOUNDS, BURNS AND DERMAL ULCERS. MX9304601A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MX9304601A MX9304601A (en) 1993-07-30 1993-07-30 ANTIMICROBIAL, ANALGESICAL, ANTI-INFLAMMATORY COMPOSITION, WHICH FAVORS LACICATRIZATION OF WOUNDS, BURNS AND DERMAL ULCERS.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX9304601A MX9304601A (en) 1993-07-30 1993-07-30 ANTIMICROBIAL, ANALGESICAL, ANTI-INFLAMMATORY COMPOSITION, WHICH FAVORS LACICATRIZATION OF WOUNDS, BURNS AND DERMAL ULCERS.

Publications (1)

Publication Number Publication Date
MX9304601A true MX9304601A (en) 1995-01-31

Family

ID=19744796

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9304601A MX9304601A (en) 1993-07-30 1993-07-30 ANTIMICROBIAL, ANALGESICAL, ANTI-INFLAMMATORY COMPOSITION, WHICH FAVORS LACICATRIZATION OF WOUNDS, BURNS AND DERMAL ULCERS.

Country Status (1)

Country Link
MX (1) MX9304601A (en)

Similar Documents

Publication Publication Date Title
ES2255107T3 (en) PROMOTION OF WOUND CICATRIZATION BY CHEMICALLY MODIFIED TETRACICLINES.
UA41989C2 (en) PHARMACEUTICAL COMPOSITION IN THE FORM OF A GEL FOR THE TREATMENT OF SKIN DISEASES AND A METHOD OF TREATMENT OF INFECTED SKIN
CO4970691A1 (en) COMBINATION THERAPY TO ERADICATE DETECTABLE HCV-RNA IN PATIENTS WITH CHRONIC HEPATITIS C INFECTION
EP1736152A3 (en) Physiologically stable compositions of butyric acid as well as butyric acid salts and derivatives for treating wounds
BR9715022A (en) Method for treating prostate disease using systematic and / or prolonged release of vitamin D formulations
BRPI0011640B8 (en) oligosaccharide aldonic acids and their topical use
ES2166783T3 (en) ACTIVATED FACTOR VIII USED AS A THERAPEUTIC AGENT AND METHOD FOR THE TREATMENT OF FACTOR DEFICIENCY VIII.
BRPI9908182B8 (en) wound healing matrix protein compositions
DE3856018D1 (en) Use of a disaccharide polysulfate-aluminum compound for the manufacture of a medicament for the treatment of HÄMORRHOIDEN and for wound healing
ATE162399T1 (en) TERFANADINE METABOLITES AND THEIR OPTICALLY PURE ISOMERS FOR THE TREATMENT OF ALLERGIC DISEASES
ES2149775T3 (en) COMPOSITION FOR THE TREATMENT OF TISSUES INCLUDING FIBRIN OR FIBRINOGEN AND A BIODEGRADABLE AND BIOCOMPATIBLE POLYMER.
AU8335291A (en) Drugs, their manufacture, and their use as painkillers and/or to treat inflammations in humans and animals
ES2136618T3 (en) WOUND HEALING.
AR002254A1 (en) ANTITHROMBOTIC FORMULATION AND PROCEDURE FOR ITS MANUFACTURE
ATE187649T1 (en) USE OF TISSUE FACTOR INHIBITOR FOR PRODUCING A MEDICINAL AGAINST MICROVESSIONAL THROMBOSIS
ES2184145T3 (en) SULPHONIC ACID OR SULFONYLAMINE ACIDS-N- (HETEROARALQUIL) -AZAHETEROCICLILAMIDA.
DE4394931T1 (en) Use of norastemizole for the treatment of allergic diseases
DK0671414T3 (en) Dermatane sulfate composition as antithrombotic agent
DE60031016D1 (en) Use of antiseptics for the preparation of medicaments for the prophylaxis and treatment of inflammation in the interior of the human body
BR0214075A (en) Unit dosage comprising a prostaglandin analog to treat constipation
DE69426530D1 (en) PHARMACEUTICAL COMPOSITION TO PROMOTE TISSUE HEALING AND REGENERATION AND PHARMACEUTICAL SET
ATE126061T1 (en) USE OF LITHIUM FOR THE TREATMENT OR PROPHYLAXIS OF MOLLUSCUM CONTAGIUSUM.
ES2058977T3 (en) ABSORBABLE PREPARATION BY VIA PERCUTANEA BASED ON EPERISONE OR TOLPERISONE.
DE69921678D1 (en) COMPOSITION CONTAINING DI- AND TRINATRIUM SALTS OF ECHINOCHROME FOR THE TREATMENT OF EYE DISEASES
BR0115215A (en) Method for treating inflammation